Leocadio C, Garcia EA, Lash M, Berardi J, Chan J, Chasan R, Esquivel B, Foote M, Glesby MJ, Guerra A et al..
2026.
Clinical Outcomes of Mpox Disease in Patients Treated With Tecovirimat.. Clin Infect Dis. 82(4):720-726.
Byun JY, Jones R, Iriarte E, Hall CDXavier, Krause KD, Wang CX, Pahwa S, Lam JO, Falutz J, Masters MClare et al..
2026.
Current Perspectives and Emerging Directions in Research and Practice: Highlights from the 15th Annual International Workshop on Aging and HIV.. J Gerontol A Biol Sci Med Sci.
Rubin LH, Xu Y, Wu S, Coughlin JM, Brown TT, Dastgheyb RM, Pohlenz L, Shirk E, Romero H, Veenhuis RT et al..
2026.
Low-Dose Hydrocortisone and Cognition in Women With HIV: A Randomized Clinical Trial.. JAMA Netw Open. 9(8):e2629185.
Umbleja T, Zafar MU, McCallum S, Gattu AK, Zanni MV, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Currier JS, Sponseller CA et al..
2026.
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis.. Lancet HIV. 13(5):e316-e326.
Zhang S, Thomas C, Marcelin K-A, Siegler E, Derry-Vick H, Yang HSarina, De Main A, Kapadia S, M Reid C, Glesby M et al..
2026.
Substance use trends across the lifespan in older adults with HIV and mental health outcomes. Journal of Substance Use. :1-6.
Zucker J, Fischer WA, Zheng L, McCarthy C, Saha PT, Javan ACyrus, Greninger A, Hamill MM, Leslie K, Brooks KM et al..
2026.
Tecovirimat for the Treatment of Mpox.. N Engl J Med. 394(9):884-895.